Delivery Order SPE2DB22D3301-SPE2DB24FZ3CP

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,267.16 for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The contract was awarded on July 2, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of July 3, 2024. This order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. The...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp's Corporate Office Division a $1,096.10 firm fixed-price delivery order contract for Lantus Solostar 100 unit/ml 3ml insulin pens. This order is part of a larger single-award Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,187.60 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. The contract has an ultimate completion date of August 6, 2024 and is not set aside for any special designations. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lantus Solostar insulin pens (100 unit/ml, 3ml) to support federal healthcare programs. The $1,828.39 delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense that procures medical supplies for military treatment facilities and other federal medical institutions. The contract is a firm-fixed price delivery...
This federal contract award is a delivery order (SPE2DX24FPYSV) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. The $12,320.62 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain for the ultimate delivery of these medical supplies by September 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens. The $1,913.52 Firm Fixed Price delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order valued at $1,187.60 with a firm-fixed price. It is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens, a critical medication used to manage diabetes. The award has an ultimate completion date of August 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/mL, 3mL insulin pens. The contract is a Delivery Order with a Firm Fixed Price of $2,484.48 and an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. This appears to be a task order under a larger...
This federal contract award is for the delivery of Lantus Solostar 100 Unit/ML 3ML insulin pens to the Defense Logistics Agency (DLA). The $1,980.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024. The contract has an ultimate completion date of December 10, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract is a delivery order valued at $2,110.95 with a period of performance through September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999, for the...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ3CP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $1,258.24 firm-fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. This order is being placed under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which provides a range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by August 19, 2024. As a key supplier of pharmaceutical and medical products to various federal agencies, Amerisourcebergen leverages its extensive supply chain capabilities to deliver critical care materials, including prescription medications, vaccines, and medical equipment, to military and civilian healthcare providers.

Generated 11/15/24, 9:02 AM